Tower Research Capital LLC (TRC) - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 102 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2023$1,036
-93.1%
691
-92.7%
0.00%
-100.0%
Q2 2023$15,102
+150920.0%
9,498
-37.8%
0.00%
Q1 2023$10
-33.3%
15,281
-39.2%
0.00%
-100.0%
Q4 2022$15
-99.9%
25,144
+5.4%
0.00%
Q3 2022$22,000
+120.0%
23,866
+200.6%
0.00%
Q2 2022$10,000
-78.7%
7,940
-78.0%
0.00%
Q1 2022$47,000
+261.5%
36,038
+376.6%
0.00%
Q4 2021$13,000
-63.9%
7,561
-54.0%
0.00%
-100.0%
Q3 2021$36,000
-40.0%
16,438
-3.6%
0.00%
-50.0%
Q2 2021$60,000
-43.4%
17,045
+58.3%
0.00%0.0%
Q1 2021$106,000
+20.5%
10,768
+32.2%
0.00%
-33.3%
Q4 2020$88,000
+25.7%
8,145
+19.0%
0.00%
+200.0%
Q3 2020$70,000
-59.5%
6,842
-17.2%
0.00%
-85.7%
Q2 2020$173,000
+458.1%
8,262
+210.0%
0.01%
+133.3%
Q4 2019$31,000
-65.6%
2,665
-83.9%
0.00%
-50.0%
Q3 2019$90,000
+900.0%
16,542
+844.7%
0.01%
+500.0%
Q1 2019$9,000
-69.0%
1,751
-81.0%
0.00%
-50.0%
Q4 2018$29,000
+2800.0%
9,202
+4794.7%
0.00%
Q2 2018$1,000
-97.7%
188
-97.5%
0.00%
-100.0%
Q1 2018$44,000
+238.5%
7,608
+110.2%
0.00%
+300.0%
Q3 2017$13,000
+62.5%
3,619
+19.7%
0.00%0.0%
Q2 2017$8,000
-38.5%
3,024
-35.3%
0.00%0.0%
Q1 2017$13,000
+62.5%
4,676
+80.8%
0.00%0.0%
Q4 2016$8,000
+700.0%
2,586
+762.0%
0.00%
Q3 2016$1,000
-93.3%
300
-93.8%
0.00%
-100.0%
Q2 2016$15,0004,8300.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2021
NameSharesValueWeighting ↓
BML Capital Management, LLC 3,915,000$5,872,5005.39%
Versant Venture Management, LLC 5,068,233$7,602,3504.04%
Sonic GP LLC 2,000,000$3,000,0002.91%
COMMODORE CAPITAL LP 10,000,000$15,000,0001.75%
VR Adviser, LLC 6,573,300$9,859,9501.04%
AIGH Capital Management LLC 1,323,985$1,985,9770.94%
Newtyn Management, LLC 1,025,000$1,537,5000.38%
Worth Venture Partners, LLC 331,668$497,5020.30%
Acuitas Investments, LLC 291,169$436,7540.26%
Quinn Opportunity Partners LLC 398,298$597,4470.08%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders